Skip to main content
SpringerLink
Log in

Opposition to patent applications for sofosbuvir

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. I-MAK. THE GROUNDS FOR OPPOSING PATENTS ON SOFOSBUVIR IN ARGENTINA, BRAZIL, CHINA, UKRAINE AND RUSSIA: Briefing document, 20 May 2015. Internet Document : 2 Jun 2015. Available from: URL: http://static1.1.sqspcdn.com/static/f/129694/26244685/1432089253573/briefing%B1note_HepC_sofosbuvir_PatentOppositions_20%B1May%B12015.pdf

  2. Bagcchi S. Campaigners challenge patent applications for hepatitis C drug in five countries. British Medical Journal 2015: h2938, No. 350, 1 Jun 2015. Available from: URL: http://dx.doi.org/10.1136/bmj.h2938

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Opposition to patent applications for sofosbuvir. PharmacoEcon Outcomes News 729, 5 (2015). https://doi.org/10.1007/s40274-015-2162-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2162-2

Search

Navigation